Group items tagged

Tynor Tummy Trimmer or Abdominal Belt Tummy Trimmer/Abdominal belt supports and compresses the abdominal muscles for waist line reduction and is used as a post operative or post delivery aid. Perfect elasticity. Breathable materials. Dermophillic. No rolling over, no buckling. Tynor Tummy Trimmer or Abdominal Belt Features Extra porous three panel webbing improves ventilation and comfort of the patient. Broad hook and loop tape panel offers better holding and size adjustability. Optimal compression, tones up abdominal muscles following surgery, CS or delivery. Optimal compression binds surgical incisions of abdomen & chest, improves healing. Holds the incision, provide analgesic effect during sudden movements or coughing. Special nylon reeves prevent rolling over of belt. Can be used in ventral hernia. Tynor Tummy Trimmer or Abdominal Belt Measurements Tummy Trimmer / Abdominal Belt 8 Measure circumference around the waist immediately below the navel.

A follow up study was conducted for a period of one year on nearly 10,000 women in a Pittsburg obstetrical hospital. It showed that nearly 1 out of 7 women faced postpartum blues after their delivery. They had been judged on the basis of a brief telephonic interview conducted about four to six weeks after the delivery of their babies.

Refurbished Abbott Hospira Plum A+ 3 Infusion Pump. The A+3 is a triple channel pump that allows each channel to be programmed and ran individually. Delivery rates in include primary, secondary and concurrent. The A+3 allows for a variety of delivery units including: mL/hr, mcg/kg/min, mcg/min, mcg/kg/hr, cg/hr, mg/min, mg/kg/hr, mg/hr, ng/kg/min, g/hr, mEq/hr, Million units/hr, units/min, units/hr, units/kg/hr, units/kg/min, mmol/min, mmol/hr. *Refurbished *1-Year Warranty

Refurbished Abbott Hospira Plum A+ 3 Infusion Pump. The A+3 is a triple channel pump that allows each channel to be programmed and ran individually. Delivery rates in include primary, secondary and concurrent. The A+3 allows for a variety of delivery units including: mL/hr, mcg/kg/min, mcg/min, mcg/kg/hr, cg/hr, mg/min, mg/kg/hr, mg/hr, ng/kg/min, g/hr, mEq/hr, Million units/hr, units/min, units/hr, units/kg/hr, units/kg/min, mmol/min, mmol/hr. *Refurbished *1-Year Warranty

Cerebral palsy (CP) is a group of conditions caused by medical abnormalities in the development of a fetus or the early life of a child. These lead to damage or delayed development in the brain. The disorder is permanent and, though it does not worsen with age, the level of functionality of a person with cerebral palsy varies widely: in some cases, effects may be very minor, while in others, movement is impaired to the extent that a wheelchair is required. Common complications associated with CP vary by the type of CP disorder but can include vision problems, seizures, learning disabilities, and issues speaking, writing, and performing other tasks related to motor control. Cerebral palsy is the focus of a large amount of medical research every year. Though much of this research deals with younger patients, more and more attention is being paid to CP sufferers as they age and seek fuller opportunities and more integration with the rest of society. Living with CP is a daily challenge, but paths to a richer and more fulfilling life are being found. There is not, and may never be a "cure" for CP, but greater understanding by clinicians and the daily success stories of those who overcome their limitations are making. Buy online CP Wheelchair, Pediatric Cerebral Palsy Wheelchair, Cerebral Palsy Wheelchair, CP Child Wheelchair for handicapped and disabled at lowest price and cheap cost in india from wheelchair india online shopping store of Karma CP Wheelchair, Pediatric Wheelchair, Cerebral Palsy Wheelchair, CP Child Wheelchair at low price in india. Causes of Cerebral Palsy Cerebral palsy is generally caused by developmental issues during pregnancy which lead to abnormal conditions in the brain. During the birth process, lack of oxygen caused by premature delivery or delivery-room errors can cause brain damage that facilitates cerebral palsy. Cerebral palsy can also be caused by recognizable brain injuries sustained by the developing child up to an early

Refurbished Abbott Hospira Plum A+ 3 Infusion Pump. The A+3 is a triple channel pump that allows each channel to be programmed and ran individually. Delivery rates in include primary, secondary and concurrent. The A+3 allows for a variety of delivery units including: mL/hr, mcg/kg/min, mcg/min, mcg/kg/hr, cg/hr, mg/min, mg/kg/hr, mg/hr, ng/kg/min, g/hr, mEq/hr, Million units/hr, units/min, units/hr, units/kg/hr, units/kg/min, mmol/min, mmol/hr. *Refurbished *1-Year Warranty

PRODUCT DESCRIPTION PEDI SPIN CALLUS REMOVER IN PAKISTAN OpenTeleShop Pedi Spin fast and simple and gentle way to enjoy a beautiful smooth soles. Pedi Spin in Pakistan OpenTeleShop electronic foot file removes the fabric, patches of raw skin Dead effort from your heel, and toes, soles, leaving them soft and gorgeous salon.Pedi Spin Callus Remover easy to use and is completely painless, and are caught in the trap of all the shavings storage so theres no mess. Pedi Spin offers two different speeds to help you remove the light and heavy callouses.Safe And 100% Working Products For Women Beauty. PEDI SPIN CALLUS REMOVER FEATURES 1-A well established brand 2-Pedicure Home Electronic System 3-Removes dead skin and tissue 4-Papers presented at a silky smooth and soft 5-Totally painless and gentle on your feet 6-Offers high and low speed settings 7-Comfortable and easy to use 8-Panel deposit to remove tissue PEDI SPIN CALLUS REMOVER PRICE IN PAKISTAN:2000/PKR OpenTeleShop offers a Best Pedi Spin Callus Remover Price in Pakistan 1999/- Home Delivery, Payment on Delivery, Available all Cities of Pakistan. Like Karachi, Hyderabad, Lahore, Islamabad, Okara, Sialkot, Gujranwala, Faisalabad, Peshawar, Quetta, Multan, jhelum, Wah Cantt, Gujrat, Rawalpindi and All Over the Pakistan.

The commencement of the weight management campaign has been postponed from the scheduled date of January 4, 2022 due to delay in the delivery of the campaign resource packs, Pharmaceutical Services Negotiating Committee (PSNC) stated. After a new delivery date for the resource packs has been confirmed, PSNC will announce the new start date for the programme, which is the third mandated health campaign for 2021/22.

Since the introduction of the 2019 NHS Long-Term Plan, several policy commitments have surfaced, presenting a definitive 'blueprint' for community pharmacy in England. The Company Chemists Association has identified four crucial commitments that, when integrated, hold the potential to revolutionise patient care through community pharmacies. "Each commitment is like a crucial piece of a puzzle," CCA said. "For the transformation of patient access through community pharmacy to be successful, all these pieces must come together harmoniously. Otherwise, the picture will remain incomplete." The four major pieces of the puzzle coined by CCA include: * Building on education and training reforms to increase the size and capability of the workforce. * Expanding the number of clinical services commissioned and delivered in community pharmacy. * Introducing digital enablers which underpin service delivery. * Introducing legislative changes to increase capacity and allow the delivery of more patient-facing clinical care.

Pharmacy professionals to be included as key stakeholders in the implementation, delivery and evaluation of a wide range of genomic services, said the Royal Pharmaceutical Society (RPS). RPS's statement has been developed in collaboration with pharmacy organisations who have co-badged the report, such as the British Oncology Pharmacy Association, the UK Clinical Pharmacy Association, Association of Pharmacy Technicians and the College of Mental Health Pharmacy. It looks at current and future roles for pharmacy professionals in genomic medicine across many aspects of practice such as person-centred care and collaboration, professional practice, education, leadership, management and research. Pharmacists and pharmacy technicians in the UK have already established roles in the application of genomic medicine in some areas of practice, such as antimicrobial stewardship and infectious diseases, and the management of certain genetic conditions, such as cystic fibrosis. The society believes, the current role of pharmacy professionals in genomics can be expanded upon in the future to both lead and support many relevant aspects of genomic implementation. These are described across all healthcare sectors, within the Genome UK strategy produced by the UK Government, and within the implementation plans published in England, Scotland and Wales. Lead for Pharmacogenomics at RPS Sophie Harding said: "Pharmacy professionals are the gatekeepers of medication safety and efficacy across all areas of healthcare. They are skilled at interpreting complex scientific data and use evidence-based medicine to maximise the benefits of treatments for patients, whilst supporting shared decision-making with patients and the multidisciplinary team.

There is clear evidence that the majority of distance selling pharmacies are operating in breach of their NHS contracts, and a failure to properly regulate 'pseudo' distance selling pharmacies is leading to local pharmacy closures, the Company Chemists' Association has reported. According to the CCA's recent findings, 72 per cent of DSPs dispense over 50 per cent of their prescriptions to patients within a single postcode area within 10 miles of the pharmacy. "Operating within constrained geographical regions, pseudo-DSPs achieve reduced overheads and operational costs by focusing on localised marketing and medicine delivery. They compete against local brick-and-mortar pharmacies, causing them to lose vital trade," the CCA claimed, based on its recent survey - The Impact of Pseudo Distance Selling Pharmacies. "As per their terms of service, DSPs are obligated to provide prescription delivery nationwide, extending beyond local patients," said the CCA, adding that the financial savings resulting from the lack of patient access are balanced by the necessity to function on a national scale.

harac, an NHS-integrated one-stop platform for independent community pharmacies, and the National Pharmacy Association (NPA) have announced their long-term partnership to allow pharmacies to deliver the broad range of services needed to support the public. The NPA and Charac will collaborate with members of the NPA and beyond to accelerate the necessary digital transition of independent community pharmacies, particularly given their importance to poorer communities and less advantaged individuals at high risk due to potential pharmacy closures. The partnership is part of the NPA's efforts to improve the online presence of community pharmacies, including patient application, online booking, website design, and a delivery service. With Charac similarly dedicated to bettering digital interaction with patients, the new joint ecosystem will provide pharmacies with the necessary funding and cutting-edge technology to aid delivery of primary care.

Prime minister Rishi Sunak appointed Conservative MP for North East Cambridgeshire Steve Barclay as secretary of state for health and social care on 25 October 2022. He previously held the same role between 5 July and 6 September - after Sajid Javid resigned as health secretary. As head of the Department of Health and Social Care (DHSC) his responsibilities will include "overall financial control and oversight of NHS delivery and performance" as well as "oversight of social care policy". Mr Barclay was succeeded by Thérèse Coffey, who thanked her "great ministerial team" at the DHSC in a Tweet, before taking up her new responsibility as environment secretary in the new cabinet. As head of the Department of Health and Social Care (DHSC) his responsibilities will include "overall financial control and oversight of NHS delivery and performance" as well as "oversight of social care policy". Mr Barclay was succeeded by Thérèse Coffey, who thanked her "great ministerial team" at the DHSC in a Tweet, before taking up her new responsibility as environment secretary in the new cabinet.

Online retail giant Amazon said on Tuesday (January 24) it is offering a $5 monthly subscription plan for U.S. Prime members that will cover a range of generic drugs and their doorstep delivery, furthering the ecommerce giant's push into healthcare. The program, named RxPass, includes more than 50 medications addressing over 80 chronic conditions such as high blood pressure, anxiety, diabetes and male pattern baldness, Vin Gupta, Amazon Pharmacy's chief medical officer, has said. However, customers enrolled in Medicare, Medicaid or any other government healthcare program will not be able to enrol in Amazon Pharmacy's RxPass service. The average Prime member would save about $100 per year with RxPass, John Love, vice president of Amazon Pharmacy, said. Amazon Prime members in most U.S. states can sign up for the program from January 24. The flat $5 charge would be without insurance and on top of the Prime membership fee, which costs $139 per year in the United States.

Despite being relatively new to the dispensing doctor market as a short-liner, Bestway Medhub is seeing exponential growth in the market in addition to the 3,500 independent pharmacies that we service and deliver to. We have however been servicing the dispensing doctor market for well over 40 years through our dispensing appliance contractor (DAC) Wardles. Wardles service and supply more than 55% of all dispensing sites with dressings, bandages, appliances, ostomy, wound care and hosiery. Graham Burford-Row To meet the needs of dispensing practices and surgeries we carry a large range of more than 10,000 Generics, PI's and OTC products. We offer net pricing so the practice can see straight away what price they are paying for their products - with no hidden fees. We offer all our practices 24-hour online ordering via our Bestway Medhub ordering portal and our recently launched Wardles FP Portal. Additionally, we have the backup of a telesales department with personal service from myself and a dedicated Internal Dispensing Dr Account Manager. We offer daily, weekly or monthly calls to those customers wishing to hear our special offers. Our deliveries are done daily via our third party full-line logistics partner for efficient deliveries, which no other short-line wholesaler offers. Bestway Medhub understands that dispensing practices are not only in the business of offering superior care to their patients and community, but they also offer numerous other services like clinics, nursing and referrals. By enabling practices to cost save, the funds could be used elsewhere instead.

The Royal Pharmaceutical Society (RPS) has awarded Professor Abdul Basit with the RPS Harrison Memorial Medal for an outstanding contribution to advancing pharmaceutical science. Professor Basit graduated with a First Class Honours degree in Pharmacy from the University of Bath, and received his PhD from The School of Pharmacy, University of London. Currently in position as Professor of Pharmaceutics at the UCL School of Pharmacy, he is internationally recognised for leading in the field of drug delivery, microbiome medicines, three-dimensional printing of pharmaceuticals and digital health. He has also founded three start-up companies. Professor Basit has an impressive track record of publications, and a lifetime grant and investment income of over £100million pounds. His research has led to a series of transformative drug delivery systems, translated into the design of new technologies and improved therapies, many of which have been commercialised and launched worldwide including a new treatment for inflammatory bowel disease. To date, more than a million patients have benefited from inventions created and developed in the Basit Research Group.

The Department of Health in Northern Ireland has acknowledged the efforts of community pharmacies, wholesalers and procurement teams in securing supply of antibiotics for the treatment of Group A Streptococcus infection in Northern Ireland. "Locally community pharmacies, wholesalers and procurement teams have been working tirelessly to secure stock deliveries into Northern Ireland. The Department acknowledges the immense efforts from all involved," it said. "To put this in context, it is estimated that around one month's worth of stock based on normal demand was exhausted in less than 48 hours last week." "While demand is well in excess of what is usual for this time of year, the system has been working hard to replenish stocks as quickly as possible, as such wholesalers are still receiving and making deliveries, with more scheduled over the coming days."

Community pharmacy chain Jardines Pharmacy has partnered with patient relationship management platform Charac to launch a new app designed to digitalise its services, enhance operational efficiency, and elevate customer satisfaction. The app allows patients to order repeat prescriptions, access medicine home delivery and book consultations with their pharmacist all in one place, enabling faster pharmacist-to-patient care. By incorporating Charac's platform into its business, Jardines is able to boost prescription dispensing efficiency, helping reducing wait times for patients. Additionally, its delivery feature enables patients to track their orders directly through the app, thereby streamlining the overall patient experience. The app also minimises administrative and manual tasks for pharmacists, giving them more time to focus on helping patients and delivering the outstanding customer service. Patients of Jardines can also use the app to book appointments digitally for Pharmacy First consultations, blood pressure checks, earwax removal, travel vaccinations, and emergency contraception services. Santosh Sahu, Founder and CEO of Charac, said: "We are pleased to support Jardines Pharmacy and its patients across England. Our mission is to ensure that community pharmacies are empowered to digitalise, making care easier and more accessible for patients.

Addressing the recent announcement made by the Department of Health and Social Care (DHSC) to claw back £9 million per month from community pharmacy contractors, the Chairman of Numark, Harry McQuillan has expressed deep concerns over the financial implications on the sector. The claw back follows an error in the July calculations of Category M medicine prices, which led to increase in the reimbursements made to community pharmacies. Beginning August, the DHSC is set to claw back the amount. McQuillan criticised the decision, highlighting the severe strain it places on already financially vulnerable community pharmacies. Calling it "a severe blow to an already financially strained sector", McQuillan emphasised that the additional burden has the potential to threaten the viability of many pharmacies. "Community pharmacies are the frontline of our healthcare system, by penalising these pharmacies for an error not of their making, the Department of Health is jeopardising the foundation of local healthcare delivery," McQuillan criticised. Addressing the recent announcement made by the Department of Health and Social Care (DHSC) to claw back £9 million per month from community pharmacy contractors, the Chairman of Numark, Harry McQuillan has expressed deep concerns over the financial implications on the sector. The claw back follows an error in the July calculations of Category M medicine prices, which led to increase in the reimbursements made to community pharmacies. Beginning August, the DHSC is set to claw back the amount. McQuillan criticised the decision, highlighting the severe strain it places on already financially vulnerable community pharmacies. Calling it "a severe blow to an already financially strained sector", McQuillan emphasised that the additional burden has the potential to threaten the viability of many pharmacies. "Community pharmacies are the frontline of our healthcare system, by penalising these pharmacies for an error not of thei

Expressing apprehension over the concerning decline in the nursing workforce, Sir Julian Hartley, CEO of NHS Providers, urged the forthcoming government to bolster investment in nursing education and enhance support for student nurses. Recent analysis from the Royal College of Nursing (RCN) has projected that the NHS Long Term Workforce Plan will fall short by 10,000 new nurses by 2025. Commenting on the RCN analysis, Sir Hartley underscored the critical importance of having an adequate number of nurses to ensure the delivery of safe, high-quality patient care. "Without enough nurses, the delivery of safe, high-quality patient care is compromised," he said. He cautioned that the predicted shortfall in nurses would exacerbate existing pressures on the NHS, resulting in long waiting times, delayed treatments and staff burnout.